Synapse

← Journal of Market Access & Health Policy

Papers in Journal of Market Access & Health Policy

Page 3 · newest first

  1. A New Health Networking Infrastructure on Cancer Is Taking Shape in Europe: A Not-to-Miss Opportunity for the EU Regulatory SystemJournal of Market Access & Health Policy · 2025
  2. Workplace Vaccination Against COVID-19 and Seasonal Influenza in the United States: A Modeling-Based Estimation of the Health and Economic Benefits for Employers and EmployeesJournal of Market Access & Health Policy · 2025
  3. Strengthening the EU Health Technology Assessment Regulation: Integrating National Immunization Technical Advisory Groups for Comprehensive Vaccine AssessmentsJournal of Market Access & Health Policy · 2025
  4. Clinical Trial Validity Guidance from the HTACG: Looking for Chicken TeethJournal of Market Access & Health Policy · 2025
  5. ARM’s Perspective on the First Joint Clinical Assessments for ATMPs: Challenges and Opportunities on the Path AheadJournal of Market Access & Health Policy · 2025
  6. Healthcare Professionals’ Perceptions About Medical Cannabis in Greece: A Qualitative StudyJournal of Market Access & Health Policy · 2025
  7. A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar DrugsJournal of Market Access & Health Policy · 2025
  8. The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UKJournal of Market Access & Health Policy · 2025
  9. The Integration of Social and Health Sectors in Scotland: An Analysis from the Prism of Different Public Policy ModelsJournal of Market Access & Health Policy · 2025
  10. Healthcare Resource Utilization (HCRU) and Direct Medical Costs Associated with Long COVID or Post-COVID-19 Conditions: Findings from a Literature ReviewJournal of Market Access & Health Policy · 2025
  11. Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access AcademyJournal of Market Access & Health Policy · 2025
  12. Musculoskeletal Magazine Advertising Focuses on White Individuals and Overlooks Minority ConsumersJournal of Market Access & Health Policy · 2025
  13. The EU Health Technology Assessment Regulation Halo Effect: Are Cross-Functional Teams Ready?Journal of Market Access & Health Policy · 2025
  14. Assessing the Value of Further Investment in R&D Using Mixed Methods: A Case Study of Biosensor-Integrated Arteriovenous GraftsENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2025
  15. Operational Efficiency of Public Hospitals in Greece During the COVID-19 Pandemic: A Comparative Analysis Using DEA and AHP ModelsSHILAP Revista de lepidopterología · 2024
  16. Managing Pharmaceutical Costs in Health Systems: A Review of Affordability, Accessibility and Sustainability StrategiesJournal of Market Access & Health Policy · 2024
  17. Gatekeeping or Provider Choice for Sustainable Health Systems? A Literature Review on Their Impact on Efficiency, Access, and Quality of ServicesJournal of Market Access & Health Policy · 2024
  18. Technology Assessment vs. Technology Appraisal—How to Strengthen the Science/Value Dichotomy with EU HTA?Journal of Market Access & Health Policy · 2024
  19. Economic Evidence on Cost Sharing and Alternative Insurance Designs to Address Moral and Behavioral Hazards in High-Income Health Care Systems: A Systematic ReviewJournal of Market Access & Health Policy · 2024
  20. Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling ApproachJournal of Market Access & Health Policy · 2024
  21. Adapting Efficiency Analysis in Health Systems: A Scoping Review of Data Envelopment Analysis Applications During the COVID-19 PandemicSHILAP Revista de lepidopterología · 2024
  22. INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in TunisiaJournal of Market Access & Health Policy · 2024
  23. A Causal Inference Approach to Mediation Analysis in Vitreomacular Traction: How Much Does Traction Resolution Mediate Functional Outcomes?Journal of Market Access & Health Policy · 2024
  24. The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of BelgiumJournal of Market Access & Health Policy · 2024
  25. Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based AnalysisJournal of Market Access & Health Policy · 2024
  26. Proposal of a Knowledge Management Model for Complex Systems: Case of the Supervision and Control Subsystem of the Colombian Health SystemJournal of Market Access & Health Policy · 2024
  27. Adoption of a Societal Perspective in Economic Evaluations of Musculoskeletal Disorders: A Conceptual PaperJournal of Market Access & Health Policy · 2024
  28. Patient Experience and Satisfaction with Orthopedic Services at a Community (Rural) Setting Hospital—How Is It Different from Urban SettingJournal of Market Access & Health Policy · 2024
  29. Valuation of Medical Innovation Handling with Uncertainty and RiskJournal of Market Access & Health Policy · 2024
  30. Market Access Challenges and Solutions in Cell and Gene Therapy in The NetherlandsJournal of Market Access & Health Policy · 2024
  31. Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect ComparisonJournal of Market Access & Health Policy · 2024
  32. Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced AlopeciaJournal of Market Access & Health Policy · 2024
  33. Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa InitiativeJournal of Market Access & Health Policy · 2024
  34. The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access AcademyJournal of Market Access & Health Policy · 2024
  35. Future Possible Changes in Medically Underserved Areas in Japan: A Geographic Information System-Based Simulation StudyJournal of Market Access & Health Policy · 2024
  36. Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve AcceptanceJournal of Market Access & Health Policy · 2024
  37. EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity?Journal of Market Access & Health Policy · 2024
  38. Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping ReviewJournal of Market Access & Health Policy · 2024
  39. Methods for Indirect Treatment Comparison: Results from a Systematic Literature ReviewJournal of Market Access & Health Policy · 2024
  40. Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver DiseaseJournal of Market Access & Health Policy · 2024
  41. An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and CollaboratorsJournal of Market Access & Health Policy · 2024
  42. Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided DeafnessJournal of Market Access & Health Policy · 2024
  43. Discounting health gain: a different viewJournal of Market Access & Health Policy · 2023
  44. Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France – the POP studyJournal of Market Access & Health Policy · 2023
  45. Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician surveyJournal of Market Access & Health Policy · 2023
  46. Women and children’s real-world economic and drug indicators from 2015 to 2019Journal of Market Access & Health Policy · 2023
  47. Ivabradine in patients with heart failure: a systematic literature reviewSHILAP Revista de lepidopterología · 2023
  48. Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatranJournal of Market Access & Health Policy · 2023
  49. Systematic literature reviews over the yearsJournal of Market Access & Health Policy · 2023
  50. Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of TunisiaJournal of Market Access & Health Policy · 2023